The expansion includes nearly 1,300 positions focused on driving innovation, improving efficiency and optimizing operations across the global company.
The expanded facilities were inaugurated in a ceremony officiated by Tamil Nadu Industries Minister T.R.B. Rajaa, British Deputy High Commissioner to India Christina Scott CMG, AstraZeneca Vice President for Asia Sylvia Varela and others.
The investment marks an important milestone in AstraZeneca's growth story in India, which this month celebrates its 45th year in the country.
With highly skilled roles to be added by 2025, the expanded GITC will drive the company's vision of leveraging technologies such as enterprise platforms, artificial intelligence, machine learning, data science and supply chain analytics to shape business outcomes. medical care.
"Technology is the driving force behind innovation and we are committed to making Tamil Nadu an epicenter of technology and research. This collaboration with AstraZeneca perfectly aligns with our vision of fostering innovation and creating high-value opportunities for the people of Tamil Nadu "We are committed to ensuring Tamil Nadu's position as a premier investment destination for businesses across the world," Tamil Nadu Chief Minister M.K.Stalin said.
Tamil Nadu Industries Minister T.R.B Rajaa said that in the last three years, Chennai has rapidly emerged as the capital of the GCC of India, leading to historic levels of office space absorption and generating jobs high quality in the state.
Referring to AstraZeneca's GCC, Rajaa said the investment will not only enhance our state's capabilities in the pharmaceutical and healthcare sectors, but also stimulate technological advancements and economic development.
"Our expansion in Chennai signifies AstraZeneca's unwavering commitment to pioneering science and innovation. India's rich talent pool and dynamic ecosystem for digital advancements make it a critical hub for our global operations," Dr. Sanjeev Panchal, CEO and National President, AstraZeneca Pharma India Limited (AZPIL).
Since its inception, the GITC in Chennai has grown from providing traditional IT services to becoming an engine of AstraZeneca's digital journey, driving productivity, simplification, technology delivery and innovation across the company's global operations, supporting the delivery of life-changing medicines to patients. world.
The facility currently occupies 334,000 square feet of office space at Ramanujan IT City, with plans to add approximately 180,000 square feet over the next six months to accommodate this expansion, creating AstraZeneca's largest global capacity center.
The expanded facilities were inaugurated in a ceremony officiated by Tamil Nadu Industries Minister T.R.B. Rajaa, British Deputy High Commissioner to India Christina Scott CMG, AstraZeneca Vice President for Asia Sylvia Varela and others.
The investment marks an important milestone in AstraZeneca's growth story in India, which this month celebrates its 45th year in the country.
With highly skilled roles to be added by 2025, the expanded GITC will drive the company's vision of leveraging technologies such as enterprise platforms, artificial intelligence, machine learning, data science and supply chain analytics to shape business outcomes. medical care.
"Technology is the driving force behind innovation and we are committed to making Tamil Nadu an epicenter of technology and research. This collaboration with AstraZeneca perfectly aligns with our vision of fostering innovation and creating high-value opportunities for the people of Tamil Nadu "We are committed to ensuring Tamil Nadu's position as a premier investment destination for businesses across the world," Tamil Nadu Chief Minister M.K.Stalin said.
Tamil Nadu Industries Minister T.R.B Rajaa said that in the last three years, Chennai has rapidly emerged as the capital of the GCC of India, leading to historic levels of office space absorption and generating jobs high quality in the state.
Referring to AstraZeneca's GCC, Rajaa said the investment will not only enhance our state's capabilities in the pharmaceutical and healthcare sectors, but also stimulate technological advancements and economic development.
"Our expansion in Chennai signifies AstraZeneca's unwavering commitment to pioneering science and innovation. India's rich talent pool and dynamic ecosystem for digital advancements make it a critical hub for our global operations," Dr. Sanjeev Panchal, CEO and National President, AstraZeneca Pharma India Limited (AZPIL).
Since its inception, the GITC in Chennai has grown from providing traditional IT services to becoming an engine of AstraZeneca's digital journey, driving productivity, simplification, technology delivery and innovation across the company's global operations, supporting the delivery of life-changing medicines to patients. world.
The facility currently occupies 334,000 square feet of office space at Ramanujan IT City, with plans to add approximately 180,000 square feet over the next six months to accommodate this expansion, creating AstraZeneca's largest global capacity center.
